GeneDx Holdings Corp. (NASDAQ: WGS) reported Q3 EPS of ($1.64), $0.46 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $53 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.